Millions of people experience some discomforting itchiness in their eyelashes at some point in their lives, especially when ...

Tarsus is developing its lead candidate TP-03, potentially the first FDA-approved therapy for Demodex blepharitis, and a pipeline of investigational therapies targeting eye care, dermatology ...